Michal Silverberg is a managing director at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Before joining NVF, she was a senior partner at Takeda Ventures and worked at Novo Nordisk in business development and new product commercialization. Since 1998, Michal has held positions in various life science industry sectors, including in the Office of the Chief Scientist of Israel, venture capital, and global pharmaceutical and biotech companies. She received her bachelor’s degree in economics and business management from Haifa University, her MBA from Tel Aviv University, and her master’s degree in biotechnology from Columbia University in New York.